Background The 2010 WHO/ICO (Institut Catala d’Oncologia) summary report states that Malaysia has a population of 8.7 million women aged 15 years and above who are at risk of developing cervical cancer. Annually, 2126 women are diagnosed with cervical cancer and 631 die from the disease. The introduction of HPV vaccine in Malaysia has significantly encouraged the introduction of molecular era which could potentially improve the future of cervical cancer screening program. This article aimed at reviewing the proposed methods published from different perspectives in improving the screening and preventive practices of cervical cancer in Malaysia.
No takes yet. Share an insight, caveat, or question.
Varatharajan et al. (2012) studied this question.